Trading Signals: MYL Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Mon. Nov. 16, 2020)(Mylan NV)
| MYL latest price $49.7300 (-0.22%) ($49.3700 - $50.0900) on Fri. Jun. 6, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.83% (three month average) | RSI | 74 | Latest Price | $49.7300(-0.22%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | MYL advances 3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support MYL advance at 0% a week (0% probability) IWM(48%) XLV(48%) SPY(45%) VT(45%) XBI(44%) | Factors Impacting MYL price | MYL will decline at least -0.915% in a week (0% probabilities). VIXM(-26%) TLT(-20%) SHY(-14%) IGOV(-8%) GLD(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.915% (StdDev 1.83%) | Hourly BBV | 0 () | Intraday Trend | -0.7% | | | |
|
5 Day Moving Average | $49.81(-0.16%) | 10 Day Moving Average | $49.42(0.63%) | 20 Day Moving Average | $48.31(2.94%) | To recent high | -7.7% | To recent low | 8.8% | Market Cap | $25.708b | | | | Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. |